-

Neogen® Renews Official Sponsorship with US Equestrian to Continue Advancing Equine Health Education

LEXINGTON, Ky.--(BUSINESS WIRE)--Neogen® Corporation (NASDAQ: NEOG) announced today that it has renewed its commitment to the United States Equestrian Federation, extending the relationship first launched last year. Since joining US Equestrian in April 2024, Neogen has provided valuable support, resources, and educational tools to benefit the Federation and its members.

As part of the renewed collaboration, Neogen and US Equestrian will once again develop member-accessible educational materials on prevention and treatment protocols for equine botulism—one of the most dangerous neuromuscular conditions in horses. This deadly neurotoxin, often referred to as a silent killer, can be found in hay, feed, and soil, posing a deadly and often overlooked threat to horses.

An industry leader in the awareness and prevention of equine botulism, Neogen manufactures BotVax® B, the only USDA-approved vaccine for botulism Type B in horses.

“It’s an honor to be working with US Equestrian and our shared commitment to equine health and safety—both in the barn and in the arena,” said Renee Hall, Head of Pet Health and Wellness for Neogen. “Continuing to offer educational outreach empowers horse owners to recognize the severity of botulism, the potentially life-threatening risks to horses, and to take preventive measures—because with horses, prevention is truly life-changing.”

“The past year of collaboration with Neogen has been incredibly impactful for both our team and our members,” said Bill Moroney, US Equestrian Chief Executive Officer. “Their commitment to providing high quality health products and forward-thinking research is exciting for the future of our sport and well-being of our equine athletes. We look forward to continued growth in this meaningful relationship.”

About Neogen

Neogen Corporation is committed to fueling a brighter future for global food security through the advancement of human and animal well-being. Harnessing the power of science and technology, Neogen has developed comprehensive solutions spanning the Food Safety, Livestock, and Pet Health & Wellness markets. A world leader in these fields, Neogen has a presence in over 140 countries with a dedicated network of scientists and technical experts focused on delivering optimized products and technology for its customers.

Neogen Corporation

NASDAQ:NEOG

Release Versions

More News From Neogen Corporation

Neogen Announces Second-Quarter 2026 Results

LANSING, Mich.--(BUSINESS WIRE)--Neogen Corporation (NASDAQ: NEOG) announced today the results of the second quarter ended November 30, 2025. “I am exceptionally proud of the Neogen team as we have initiated the first phase of our strategic transformation with early work focused on stabilizing and strengthening our core business. While it is early in the process, and our industry is currently seeing macro headwinds, our team drove significant sequential improvement in core revenue growth and pr...

Neogen® Announces Two Senior Leadership Appointments

LANSING, Mich.--(BUSINESS WIRE)--Neogen Corporation (NASDAQ: NEOG) today announced the appointments of Joe Freels as Senior Vice President and Chief Commercial Officer, effective January 5, 2026, and Dr. Tammi Ranalli as Senior Vice President and General Manager, Global Food Safety, effective January 7, 2026. As Senior Vice President and General Manager for Neogen’s Food Safety business unit, Dr. Ranalli will have full P&L responsibility for Neogen’s global Food Safety portfolio and will de...

Neogen Announces Second-Quarter Earnings Release Date

LANSING, Mich.--(BUSINESS WIRE)--Neogen® Corporation (NASDAQ: NEOG) will issue its second-quarter earnings release before the opening of the market on January 8, 2026. Executives from the company will host a webcast and conference call later that morning, beginning at 8:00 a.m. Eastern time, to discuss the financial results. The conference call can be accessed by dialing: Toll-Free - North America: 1-800-549-8228 International: (+1) 646-564-2877 Conference ID: 82072 The live webcast can be acce...
Back to Newsroom